A long term evaluation of infants who received a beta-mimetic drug while in utero by Freysz, H. et al.
94 Freysz et al., Beta mimetic drug
J. Perinat. Med.
5(1977)94
A long term evaluation of infants who received a beta-mimetic drug
while in utero
H. Freysz, D. Willard, A. Lehr, J. Messer, G. Boog
Statistical Analysis: A. Heyting
\1 Introduction
During the past few years, many pregnant women
have received prolonged administration of beta-
mimetic drugs.
This therapy does not seem to cause changes in the
glycemic balance or in hepatic function of the
newborn [3].
In the fetus some side effects due to betamimetic
drugs have been described [4, 5,6,7],
RENAUD [6, 7] noticed that sometimes the fetal
heart beats faster. However NOCHIMSON [5] could
not observe such effects. Elevated blood levels of
glucose and insulin have been described [4,7] and
it has been suggested that increased glycogenolysis
is involved [7],
According to RENAUD [7] this is accompanied by
increased lipolysis and a falling of pH and base
excess.
Before asserting the safety of such treatment, it is
important to confirm that there are no long-term
effects upon live-born infants who may have been
exposed to beta-mimetics in utero. This was our
aim in studying those infants whose mothers had
been treated with ritodrine hydrochloride (Pre-
par®): a beta-mimetic commonly used by our
obstetric colleagues.
2 Materials and methods
Two groups were studied: one of infants born to
mothers treated with ritodrine and the other of
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matched controls from untreated mothers. The
mean duration ofmaternal treatment^with ritodrine
hydrochloride was 24 days, the ränge being 3 to
93 days, with a daily dose of 60-80 mg.
Each infant in the ritodrine group was matched
with a control according to the following criteria:
l.Birthplace: (Clinique Gynecologique et Ob-
stotricale I de Strasbourg)
2. Duration of gestation at birth: within one week
if born before 33 weeks, and two weeks if born
after that.
3. Sex.
4. Birthweight: within 200 grams if born before 33
weeks and 400 grams if born after.
To comply with the strict matching criteria, we
finally had 42 pairs: 21 of each sex.
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Tab. I. Data on mothers treated with ritodrine hydrochloride whose infants were included in our study (42 cases).







delivery: all the 42 cases
Toxemia: 6 cases
Placenta praevia: 2 cases
Cholestaticj.aundice: l case






Caesarian section: 5 cases
Vaccuum extraction:
2 cases
Breech delivery: 2 cases
The clinical evaluation was always performed by
the same physician. It consisted of:
1. A detailed questionnaire covering pregnancy,
delivery; any problem during the neonatal
period; the infant's medical history and the date
when the major milestones in psychomotor
development appeared.
2. A complete medical examination.
S.Urine analysis: for proteinuria, glycosuria and
microscopy of any Sediments.
4. An electrocardiogram.
5.TheDenvertest[l,2].
Statistical analysis comparing, pair by pair, the
children of treated and untreated mothers was
performed by applying the appropriate Statistical
tests on the basis of the Tab. II.
3 Results
The two groups of infants were comparable with
the exception of duration of gestation at delivery
and birth weight (Tab. III).
The possible reason for this is discussed below. The
mean age of the two groups at the time of
examination was 24.8 months (Tab. IV). The dis-
tribution of the pairs was:
1. 12-17 months: 16%
2. 18-23 months: 34%
3. 24-29 months: 28%
4. 30-36 months: 22%
Increase in height and weight was not affected by
ritodrine, äs is shown in Tab. IV.
Tab. II. Pair by pair Statistical analysis.
a = the number of pairs for which the child of the treated mother and the control are both normal äs far äs the
examination in question is concerned.
b = the number of pairs for which the child of the treated mother is considered to be abnormal and the control child
is judged to be normal,
c = the number of pairs for which the child of the treated mother is considered to be normal and control child is judged
to be abnormal,
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Tab. IV. The ages, heights, head circumferences and weights of the two groups of infants at the time of examination.



















There was also no difference in the distribution of
physical abnormalities between the two groups
(Tab. V).
The incidence of infections was almost identical
for the two groups. There were no marked differ-
ences in the incidence of diseases of the respiratory,
digestive, cardiovascular, urino-genital and skeletal
Systems äs shown in Tab. VI.
Similarly, there was no difference in the incidence
of diseases of the central nervous system, or
psychiatric disorders between the two groups.
Examination of the children's environment and
upbringing,. both of which may have serious reper-
cussions on the psychomotor development of a
child, revealed no significant differences between
the groups.
When the actual psychomotor development of the
groups was compared, there were no differences in
the ages at which the main milestones were
attained (Tab. VII).
Analysis of the Denver tests confirmed this: there
were no pathological results althöugh three were
doubtful in each group. There was no significant
difference (P = 0.69, one-sided Sign test).
No child häd proteiriuria or glycosuria, and the
ürinäry sediment was normal in every case.
The electrocardiograms (B.C.G.) showedno change
in 36 of the infants from treated mothers, and 34
of the matched controls (P = 0.81, one-sided Sign
test).
Among the E.C.G. changes noted in the group of
infants from treated mothers were :
1. One case of shortening of the P-R interval.
2. 2 cases of inverted T waves in lead V4.
3. One case of left ventricular hypertrophy.
This last patient was re-examined more than a year
after the first examination. At this time there were
no functional signs, but ehest X-ray was reported
äs showing moderate left ventricular hypertrophy.
Tab. V. Distribution of abnormalities for the two groups of infants.
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Blood pressure was 120/80 mmHg when taken on
all four limbs. This child will be followed up, since
the Interpretation is difficult. The patient has also
had a cystic lymphangioma excised from the neck.
4 Discussion
The difference in duration of gestation at birth,
and birth weight, are to be expected. The infants
from ritodrine-treated mothers represent a threat-
ened group, otherwise the mothers would not have
been given therapy, whereas the controls are not.
It is interesting, in this context, to note that this
difference in weight had disappeared by the time
of examination.
If beta-mimetics induced an increase in pre-natal
mortality this would introduce a grave error in our
study which only concerns live-born children. Our
obstetric colleagues state that, according to their
experience, this is certainly not so [6].
There was no statistically significant difference in
the incidence of pathologies, the psychomotor
development, the clinical examination and other
investigations, between the two groups of infants.
If any discrepancy had been found it could have
been due either to the direct action of ritrodrine
hydrochloride or the factors which initiate
premature labour. To separate and weigh these
possible aetiologies, would have been extremely
difficult: fortunately it was not necessary.
4.1 Conclusion
The administration of ritodrine hydrochloride to
pregnant women is not associated with any harmful
effects to the live-born child. We would like to see
this work confirmed in other centres.


































Tab. VII. Psychomotor development in the two groups of infants
Mean age that milestones were attained (months)
Milestones in psychomotor
development Infants of treated mothers Matched controls
P-value (one-sided)
Rank's test
Able to stand unaided for
one minute
Able to walk ten Steps
unaided
Able to use 3 or 4 isolated
words
Age at which a phrase of 3
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Summary
The administration of beta-mimetic drugs to pregnant
women poses the problem of possible long-term reper-
cussions in the children born to these mothers. 42 children
from women who had been treated with 60-80 mg a day
of ritodrine hydrochloride (Pre-par®), during a period
varying from 3 to 93 day s, were closely matched with
infants from untreated mothers.
Each child, (aged from one to 3 years), was fully
investigated on the basis of: a detailed questionnaire to
the mother; careful clinical examination; assessment of
psychomotor development; t^e Denver test; electrocardio-
graphy and urine analysis.
Theie was no statistically significant diffeience between
the two groups for any of the variables of development
that were studied.
One child had left ventricular hypertrophy, which was
probably incidental.
It is concluded that administration of ritodrine hydro-
chloride to pregnant women induces no harmful long-
term effects in their off spring.
Keywords: Beta mimetic drugs, long term repercussions in children.
Zu sam menfassu ng
Langzeitüberwachung vonKindern, die eine Beta-Mimetika-
Therapie in utero erhalten haben
Die Gabe von Beta-mimetischen Substanzen an schwangere
Frauen wirft das Problem von möglichen Spätfolgen bei
den Kindern dieser Mütter auf. 42 Kinder von Frauen, die
mit 60-80 mg pro Tag Ritodrine Hydrochlorid (Pre-par)
\uber einen Zeitraum, der von 3-93 Tagen variierte, be-
handelt worden waren, wurden sorgfältig, paarweise ver-
glichen mit Kindern von unbehandelten Müttern.
Jedes der Kinder, deren Alter von 1-3 Jahren rangierte,
wurde vollständig untersucht auf der Basis von: einem
eingehenden Fragebogen für die Mutter, einer sorgfältigen
klinischen Untersuchung, einer Bestimmung der psycho-
motorischen Entwicklung, Durchführung eines Denver-
Testes sowie EKG und Urinuntersuchungen.
Es fanden sich keine statistisch signifikanten Differenzen
zwischen den beiden Gruppen bei irgend einer der Ent-
wicklungsvariablen, die untersucht worden waren.
Eines der Kinder hatte eine linksventrikuläre Hyper-
trophie, die möglicherweise zufälliger Natur war.
Aus der Untersuchung wird der Schluß gezogen, daß die
Anwendung von Ritodrine Hydrochlorid bei schwangeren
Frauen keine ernsten Langzeitwirkungen bei der Nach-
kommenschaft hervorruft.
Schlüsselwörter: Beta-mimetische Substanzen, Spätfolgen bei den Kindern.
Resume
Evolution a long terme des enfants soumis in utero a un
traitement betamimetique
La prescription de betamimetiques a des femmes gestantes
souleve le probleme d'une eventuelle repercussion tardive
sur l'enfant soumis in utero a cette therapeutique.
42 enfants de meres traitees par le Pre Par (60 a 80 mg/j)
pendant unc periode de 3 a 93 jours, sont compares a des
temoins selectionn6s sur unegamme de criteres de maniere
a constituer 42 paires homogenes.
Nos investigations pratiquees, selon les paires entre l et 3
ans, comprennent un interrogatoire soigneux, un examen
clinique detaille, une appreciation du developpement
psychomoteur, la pratique du test de Denver, d'un
electrocardiogramme et d'un examen urinaire.
L'analyse statistique n'a pas permis de mettre en evidence
de difference significative entre les 2 series concernant les
differents parametres etudies.
On peut conclure que, mise a part la decouverte chez un
enfant d'une hypertrophie ventriculaire gauche electrique
et radiologique peut etre / tfbrtuite, le traitement
betamime tiquenenous parait p^|entrainer d'inconvenients
potentiels pour l'enfant ä naitieT
Mots des: Betamimetiques, evolution a long terme, heritage medicamenteux.
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